Profusa, Inc.

Profusa, Inc., trading under the ticker NVAC, filed an 8-K with the SEC on September 13, 2023, representing a material disclosure event for the company within its public-market lifecycle. Profusa is a life sciences and digital health company focused on implantable biosensor technology, specifically continuous physiological monitoring systems, placing it squarely in the medical device and biotech sector. The company entered public markets through a SPAC structure and has maintained an active regulatory filing cadence since its combination. The September 2023 8-K is one of several disclosures on record tied to NVAC. Sign up at SpacDesk for full access to NVAC's complete filing history, sponsor details, deal timeline, and real-time SPAC intelligence.